Here, we aimed to uncover the pro‐oncogenic mechanism of DHPS in melanoma by mediating the hypusination of eIF5A to promote the m6A modification of METTL3 itself through a multi‐omics approach to elucidate the value of DHPS as a therapeutic target for melanoma. Here, METTL3 is linked to melanoma.